source
- STAT+: Pharmalittle: We’re reading about a Lilly deal, an Intellia CRISPR rare-disease treatment, and moreIntellia disclosed that a single dose of its gene editing treatment dramatically reduced swelling attacks in patients with hereditary angioedemaSTAT · 3mo ago↗ source
- What’s the true risk for eating disorders with GLP-1s?The state of Covid-19 in 2026, a hat to treat depression, and other health news from Morning RoundsSTAT · 3mo ago↗ source
- STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trialWith good results from Intellia, the CRISPR field faces the question: How attractive will the one-and-done approach be to patients and doctors?STAT · 3mo ago↗ source